Levitra is owned by Bayer Hlthcare.
Levitra contains Vardenafil Hydrochloride.
Levitra has a total of 2 drug patents out of which 0 drug patents have expired.
Levitra was authorised for market use on 19 August, 2003.
Levitra is available in tablet;oral dosage forms.
Levitra can be used as treatement of erectiile dysfunction by administering a film-coated tablet.
The generics of Levitra are possible to be released after 23 July, 2027.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US8841446||BAYER HLTHCARE||Medicaments containing vardenafil hydrochloride trihydrate|| |
(5 months from now)
|US8273876||BAYER HLTHCARE||Medicaments containing vardenafil hydrochloride trihydrate|| |
(4 years from now)
Market Authorisation Date: 19 August, 2003
Treatment: Treatement of erectiile dysfunction by administering a film-coated tablet
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic